ocal cord polyp
Conditions
Interventions
Sugammadex group (experimental groups, S1):intravious injection of sugammadex sodium
Sugammadex group (experimental groups, S2):intravious injection of sugammadex sodium(When TOF-COUNT>2)
Neostigmine group (control group, N):intravious injection of neostigmine
Sponsors
Dalian Third People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients scheduled for elective suspension laryngoscope surgery under general anesthesia at the Third People's Hospital of Dalian, Liaoning Province.These patients were aged 18-65 years, BMI 18-28 kg/m^2, and classified as ASA I-II.
Exclusion criteria
Exclusion criteria: Exclusion criteria included patients with significant preoperative respiratory or circulatory dysfunction, liver or kidney function abnormalities, mental disorders and communication barriers, allergies to rocuronium, benzodiazepines, or any component of sugammadex sodium, and those known or suspected to have neuromuscular diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Extubation time (min); | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of bradycardia;The incidence of excessive secretion; | — |
Countries
China
Contacts
Public ContactGe Qian
Dalian Third People's Hospital
Outcome results
None listed